Gainers

  • Eton Pharmaceuticals ETON shares increased by 32.3% to $3.44 during Friday's pre-market session. The company's market cap stands at $87.7 million. As per the press release, Q2 earnings came out yesterday.
  • Sunshine Biopharma SBFM stock rose 18.09% to $0.61. The market value of their outstanding shares is at $15.1 million.
  • Semler Scientific SMLR stock rose 17.76% to $27.64. The company's market cap stands at $189.3 million. As per the news, the Q2 earnings report came out yesterday.
  • BiomX PHGE shares increased by 14.33% to $0.43. The company's market cap stands at $19.7 million. As per the news, the Q2 earnings report came out 2 days ago.
  • Senti Biosciences SNTI stock moved upwards by 12.59% to $0.9. The company's market cap stands at $39.7 million.
  • Fresh2 Group FRES stock rose 12.15% to $3.6. The company's market cap stands at $22.5 million.

Losers

  • Yield10 Bioscience YTEN stock fell 56.5% to $0.44 during Friday's pre-market session. The market value of their outstanding shares is at $2.6 million.
  • Cano Health CANO stock decreased by 48.06% to $0.79. The company's market cap stands at $220.2 million. The company's, Q2 earnings came out yesterday.
  • Joint JYNT stock decreased by 20.5% to $10.05. The market value of their outstanding shares is at $147.5 million. The company's, Q2 earnings came out yesterday.
  • PHAXIAM Therapeutics PHXM stock declined by 15.84% to $0.5. The company's market cap stands at $30.4 million.
  • Biote BTMD shares fell 15.28% to $5.49. The market value of their outstanding shares is at $110.3 million. As per the news, the Q2 earnings report came out yesterday.
  • Apyx Medical APYX shares declined by 13.2% to $3.65. The market value of their outstanding shares is at $126.3 million. As per the press release, Q2 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!